Algert Global’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.72M Buy
100,465
+35,420
+54% +$3.63M 0.15% 211
2025
Q4
$6.9M Buy
65,045
+2,060
+3% +$239K 0.11% 323
2025
Q3
$8M Buy
62,985
+22,010
+54% +$2.62M 0.13% 251
2025
Q2
$5.03M Sell
40,975
-66,824
-62% -$7.63M 0.11% 328
2025
Q1
$10.9M Sell
107,799
-65,345
-38% -$6.38M 0.27% 79
2024
Q4
$16M Buy
173,144
+22,574
+15% +$2.22M 0.38% 21
2024
Q3
$14.6M Buy
150,570
+71,132
+90% +$6.39M 0.39% 23
2024
Q2
$6.82M Buy
79,438
+53,238
+203% +$4.47M 0.23% 114
2024
Q1
$2.16M Buy
26,200
+9,450
+56% +$692K 0.08% 387
2023
Q4
$1.12M Buy
16,750
+3,230
+24% +$209K 0.05% 593
2023
Q3
$908K Buy
+13,520
New +$930K 0.04% 585
2023
Q1
Sell
-8,874
Closed -$531K 1174
2022
Q4
$531K Hold
8,874
0.03% 788
2022
Q3
$401K Buy
+8,874
New +$444K 0.02% 867
2021
Q4
Sell
-6,902
Closed -$412K 1007
2021
Q3
$412K Buy
+6,902
New +$434K 0.05% 620

Other funds holding EHC

Algert Global's EHC Position: Q1 2026 in Review

Algert Global increased its Encompass Health (EHC) stake by 54% in Q1 2026, buying an estimated $3.63M and bringing the position to 100,465 shares worth $9.72M. The position accounts for 0.15% of the portfolio, ranked #211.

Algert Global first reported a position in EHC in Q3 2021 and has held it in 14 quarters since. The position peaked at $16M in Q4 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Algert Global held 100,465 shares of Encompass Health worth $9.72M as of Q1 2026.
  • Algert Global bought 35,420 Encompass Health shares in Q1 2026, an estimated $3.63M.
  • Encompass Health made up 0.15% of Algert Global's portfolio in Q1 2026, its #211 holding.
  • Algert Global first reported a position in Encompass Health in Q3 2021 and has held it in 14 quarters since.
  • Algert Global's Encompass Health position peaked at $16M in Q4 2024.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.